News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
Partners

Charles E. Geyer, MD, FACP

Articles by Charles E. Geyer, MD, FACP

Dr. Geyer Highlights Optimal Dosing Strategies for New Olaparib Indication in Breast Cancer

Dr. Geyer Highlights Optimal Dosing Strategies for New Olaparib Indication in Breast Cancer

ByCharles E. Geyer, MD, FACP

March 28th 2022

Charles E. Geyer, MD, FACP, discusses dosing strategies and adverse event management with olaparib.

Latest Updated Articles

Dr. Geyer Highlights Optimal Dosing Strategies for New Olaparib Indication in Breast Cancer
Published: March 28th 2022 | Updated:

Trending on Oncology Nursing News

Case Study: Breast Oncology APPs Across the Cancer Continuum

Age, Parental Status Factors in Fertility Decisions in Premenopausal Breast Cancer

ADC Receives Orphan Drug Designation in Small Cell Lung Cancer